News

Age-related macular degeneration (AMD) is a progressive eye disease where the macula – the part of the retina responsible for central vision – ...
Galimedix Therapeutics completed the single ascending dose part of a phase 1 study of GAL-101, a potential oral therapy under ...
A common phrase that macular degeneration patients hear is "There's nothing more we can do". But it couldn't be furth ...
Steven T. Reed, O.D., discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults ...
If you are diabetic, keep it under control. Eat fruits and vegetables to get antioxidant vitamins. Eat fish and nuts like ...
At ARVO 2025, in Salt Lake City, Utah, Diana Do, MD, gave an update on the LIGHTSITE III study of photobiomodulation for dry age-related macular degeneration.
Researcher works with universities of California-Davis, Illinois, Wisconsin and others to engineer and test a novel microsphere-hydrogel delivery for medicine, requiring fewer injections, to treat a c ...
Yorkshire residents suffering from the sight-threatening eye condition glaucoma have faced long delays for treatment. But now ...
To further our strategic development plan, preparing to initiate the open-label tanruprubart FORWARD study, measuring pharmacokinetics, pharmacodynamics, early efficacy in week 1, and safety in up to ...
Tutt Street Optometry has been a cornerstone of eye care in Kelowna for nearly four decades, and its passion for improvement ...
In this Healio Video Perspective from the Retina World Congress, Reenie McCarthy, CEO of Stealth BioTherapeutics, discusses ...
The extension trial findings for LumiThera’s Valeda dry AMD treatment suggest longer treatment and earlier intervention increase benefits.